📖 < 1 min. For almost a decade there has been a growing interest in Dicholoroacetates potential to successfully get rid of cancer while causing minimal harm to healthy organs. DCA is a relatively cheap substance which cannot be patented by the pharmaceutical industry, thus it could not generate profit for private drug companies. Right now, because of this … Continue reading DCA papers and clinical trials